Strub C - Search Results

1

Scabies outbreak in an intensive care unit with 1,659 exposed individuals--key factors for controlling the outbreak.

Buehlmann M, Beltraminelli H, Strub C, Bircher A, Jordan X, Battegay M, Itin P, Widmer AF. Buehlmann M, et al. Among authors: strub c. Infect Control Hosp Epidemiol. 2009 Apr;30(4):354-60. doi: 10.1086/596113. Infect Control Hosp Epidemiol. 2009. PMID: 19254159 Free article.

2

Scabies, boring skin and psyche. A situation report.

Beltraminelli H, Widmer AF, Jordan X, Strub C, Bircher AJ, De Lorenzo R, Herold R, Schuhmacher H, Buehlmann M, Itin P. Beltraminelli H, et al. Among authors: strub c. Dermatology. 2009;219(1):1-2. doi: 10.1159/000207688. Epub 2009 Mar 6. Dermatology. 2009. PMID: 19270437 Free article. No abstract available.

3

[Exanthema with emphasis of body flexure points 10 hours after administration of amoxicillin, "baboon syndrome"].

Strub C, Bircher AJ. Strub C, et al. Praxis (Bern 1994). 2002 Feb 6;91(6):232-4. doi: 10.1024/0369-8394.91.6.232. Praxis (Bern 1994). 2002. PMID: 11875845 German. No abstract available.

4

Systemic allergic dermatitis reaction to nickel released from an eyelet in an intravenous catheter.

Bircher AJ, Schmidli F, Strub C, Müller B, Scherer K. Bircher AJ, et al. Among authors: strub c. Contact Dermatitis. 2009 Sep;61(3):180-2. doi: 10.1111/j.1600-0536.2009.01587.x. Contact Dermatitis. 2009. PMID: 19780778 No abstract available.

5

Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes.

Hansjee N, Kaufmann GR, Strub C, Weber R, Battegay M, Erb P; Swiss HIV Cohort Study. Hansjee N, et al. Among authors: strub c. J Acquir Immune Defic Syndr. 2004 Jun 1;36(2):671-7. doi: 10.1097/00126334-200406010-00003. J Acquir Immune Defic Syndr. 2004. PMID: 15167285

6

Gynecomastia and potent antiretroviral therapy.

Strub C, Kaufmann GR, Flepp M, Egger M, Kahlert C, Cavassini M, Battegay M; Swiss HIV Cohort Study. Strub C, et al. AIDS. 2004 Jun 18;18(9):1347-9. doi: 10.1097/00002030-200406180-00019. AIDS. 2004. PMID: 15362673 No abstract available.

7

Topical bioavailability of triamcinolone acetonide: effect of dose and application frequency.

Pellanda C, Ottiker E, Strub C, Figueiredo V, Rufli T, Imanidis G, Surber C. Pellanda C, et al. Among authors: strub c. Arch Dermatol Res. 2006 Oct;298(5):221-30. doi: 10.1007/s00403-006-0677-x. Epub 2006 Jul 21. Arch Dermatol Res. 2006. PMID: 16858572 Clinical Trial.

8

Topical bioavailability of triamcinolone acetonide: effect of occlusion.

Pellanda C, Strub C, Figueiredo V, Rufli T, Imanidis G, Surber C. Pellanda C, et al. Among authors: strub c. Skin Pharmacol Physiol. 2007;20(1):50-6. doi: 10.1159/000096172. Epub 2006 Oct 11. Skin Pharmacol Physiol. 2007. PMID: 17035722 Clinical Trial.

9

[Sub-Saharan traveler with papulovesicular exanthema and flu-like symptoms].

Strub C, Weisser M, Bassetti S. Strub C, et al. Internist (Berl). 2004 Dec;45(12):1419-22. doi: 10.1007/s00108-004-1278-4. Internist (Berl). 2004. PMID: 15365639 German.

10

Reduction in Ochratoxin A Occurrence in Coffee: From Good Practices to Biocontrol Agents.

López-Rodríguez C, Verheecke-Vaessen C, Strub C, Fontana A, Schorr-Galindo S, Medina A. López-Rodríguez C, et al. Among authors: strub c. J Fungi (Basel). 2024 Aug 20;10(8):590. doi: 10.3390/jof10080590. J Fungi (Basel). 2024. PMID: 39194915 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters